New Publication

Financing High Medical Risks

All member states of the EU are faced with the same challenges regarding accessibility, quality and sustainability of long-term care.

The book ‘Financing high medical risks’ (Edited by Karel-Peter Companje) addresses the cover for high medical risks in the Dutch, German and Norwegian welfare systems, highlighting the problems faced by the public and private parties and discussing possible solutions.
‘Financing high medical risks’ includes Discussions, Developments, Problems and Solutions on the Coverage of the Risk of Long-term Care in Norway, Germany and the Netherlands since 1945 in European Perspective

Introduction
http://www.aup.nl/wosmedia/2096/financing_high_medical_risks_toc__introduction.pdf

15.01.2015

News • Economic burden of CVD

Putting a price tag on cardiovascular disease in Europe

Cardiovascular disease (CVD) cost the EU an estimated €282 billion in 2021, according to late breaking research presented at the European Society of Cardiology's ESC Congress 2023.

News • Biopharmaceutical business

Precision approach to significantly reduce R&D costs for cancer drugs

A new analysis exploring the finances of bringing new cancer drugs to market has found that precision oncology drugs could be $1 billion cheaper to develop than non-precision drugs.

News • Economic and social rights

Women’s rights strongholds are healthier, study finds

Nations with strong women’s rights are more likely to have better health and faster growth than those who don’t promote and protect these values, finds research published in the online journal…